GlassScriptPhysician profile
Amy Lynn Scheller
NPI 1255770558
$7,826.89
in general payments reported to CMS, 2019-2025
22 companies · $6,359 in 2025
The $6,359 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $145 · 2021: $639 · 2022: $64.26 · 2023: $118 · 2024: $274 · 2025: $6,359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Travel and Lodging: $1,807 · Food and Beverage: $943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Travel and Lodging | $1,807.30 |
| Food and Beverage | $942.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,780.84 | 2021-2025 | |
| Alphatec Spine, INC | $1,807.30 | 2025 | Other - Miscellaneous |
| Baxter Healthcare | $139.50 | 2025 | Tisseel |
| Allergan, INC. | $115.00 | 2019 | |
| Shire North American Group INC | $113.61 | 2019 | |
| W. L. Gore & Associates, INC. | $98.63 | 2024 | Gore Synecor Biomaterial |
| Lilly USA, LLC | $92.70 | 2025 | Zepbound, Mounjaro |
| Aroa Biosurgery Incorporated | $89.64 | 2023 | |
| Organogenesis INC. | $84.36 | 2024-2025 | Nushield, Affinity |
| Covidien LP | $78.30 | 2020 | |
| Teleflex LLC | $72.02 | 2025 | Deknatel |
| Tela Bio, INC. | $71.08 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Ethicon US, LLC | $66.75 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $58.28 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $28.32 | 2023 | Exparel |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lsi Solutions INC | $26.25 | 2021 | |
| Davol INC. | $22.31 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.04 | 2024 | Gattex |
| Conmed Corporation | $20.89 | 2024 | Airseal |
| Merck Sharp & Dohme LLC | $16.53 | 2024 | Bridion |
| Bioventus LLC | $12.23 | 2022 | |
| Innocoll Pharmaceuticals Limited | $11.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Scheller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.